{
    "2021-08-20": [
        [
            {
                "time": "",
                "original_text": "警惕！财报日业绩“爆雷”日，这些“白马股”股价或继续下跌！",
                "features": {
                    "keywords": [
                        "财报",
                        "业绩",
                        "爆雷",
                        "白马股",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821.SZ)解除限售限制性股票19.14万股",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "解除限售",
                        "限制性股票"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "一片惨绿！药明康德成新医药一哥，恒瑞还行吗？迈瑞怎么了？CXO逻辑崩没崩？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "恒瑞",
                        "迈瑞",
                        "CXO",
                        "医药行业"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "北向资金6年来首次连续两日净卖出超百亿，贵州茅台、五粮液、恒瑞医药遭惨烈抛售",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净卖出",
                        "贵州茅台",
                        "五粮液",
                        "恒瑞医药"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "CXO赛道凯莱英“凯皇”的称号还能保持多久？",
                "features": {
                    "keywords": [
                        "CXO",
                        "凯莱英",
                        "凯皇",
                        "医药行业"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}